| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.6 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |